CO 2 laser therapy shows potential benefits for treating genitourinary syndrome of menopause (GSM), particularly in reducing symptoms and improving patient satisfaction compared to a sham treatment.
The meta-analysis included six randomized clinical trials and found that CO 2 laser treatment significantly lowered scores on the Vaginal Assessment Scale and Urinary Distress Inventory short form.
While the therapy was associated with mild adverse events, no serious side effects were reported, indicating a good safety profile, but further research with larger sample sizes is recommended to validate these findings.